Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia-Reference-Cited by-同舟云学术

Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia

Published:2015-02 Issue: Volume:61 Page:64-72
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Xu Ke,Krystal John H.,Ning Yuping,Chen Da Chun,He Hongbo,Wang Daping,Ke Xiaoyin,Zhang Xifan,Ding Yi,Liu Yuping,Gueorguieva Ralitza,Wang Zuoheng,Limoncelli Diana,Pietrzak Robert H.,Petrakis Ismene L.,Zhang Xiangyang,Fan Ni^ORCID

Funder

Guangzhou Brain Hospital

Health Bureau of Guangzhou

National Institute on Drug Abuse, US

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference53 articles.

1. The NMDA antagonist model for schizophrenia: promise and pitfalls;Abi-Saab;Pharmacopsychiatry,1998

2. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers;Adler;Biol Psychiatry,1998

3. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia;Adler;Am J Psychiatry,1999

4. Comparing the PANSS in Chinese and American inpatients: cross-cultural psychiatric analyses of instrument translation and implementation;Aggarwal;Schizophr Res,2011

5. Connectivity, pharmacology, and computation: toward a mechanistic understanding of neural system dysfunction in schizophrenia;Anticevic;Front Psychiatry,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of association between resveratrol and ketamine on behavioral and biochemical analysis in mice;Journal of Neural Transmission;2024-06-14

2. Acute ketamine induces neuronal hyperexcitability and deficits in prepulse inhibition by upregulating IL-6;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-03

3. Psychopharmacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorders;Advances in Experimental Medicine and Biology;2024

4. Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: A correlation study with TH, GAD67, and PPAR-γ;Pharmacology Biochemistry and Behavior;2023-12

5. Understanding the role of the NMDA receptor subunit, GluN2D, in mediating NMDA receptor antagonist‐induced behavioral disruptions in male and female mice;Journal of Neuroscience Research;2023-10-10